Increasing age and carcinoma not otherwise specified: A 20-year population study of 40,118 lung cancer patients

Journal of Thoracic Oncology

Volumn 7, Issue 1, 2012, Pages 57-63

  Sagerup, Camilla Maria T ^a,b   Småstuen, Milada ^c   Johannesen, Tom B ^c   Helland, Åslaug ^a,b,d   Brustugun, Odd Terje ^a,b,d  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age; Carcinoma NOS; Incidence; Lung carcinoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CHILD; CLINICAL ASSESSMENT; CYTOLOGY; ELDERLY CARE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL TIME;

EID: 84655161536     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182307f7e     Document Type: Article

References (30)

1. Sagerup CM, Smastuen M, Johannesen TB, et al. Sex-specific trends in lung cancer incidence and survival: a population study of 40 118 cases. Thorax 2011;66:301-307.
2. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007;25:5570-5577.
3. Rostad H, Naalsund A, Strand TE, et al. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years. Eur J Cardiothorac Surg 2005;27:325-328. (Pubitemid 40193145)
4. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-2067. (Pubitemid 30035956)
5. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-2726. (Pubitemid 38725421)
6. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355: 2542-2550. (Pubitemid 44917502)
7. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
8. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-1231.
9. 2008 Cancer in Norway [database online]. Available at: http://kreftregis eret.no/Global/Publikasjoner%20og%20rapporter/CiN2008part1-web.pdf. ccessed June 6, 2011.
10. American Cancer Society. New York NACS. Manual of Tumor Nomenclature and Coding. New York, NY: American Cancer Society, 1968.
11. Percy C, Van Holten V, Muir C, et al. International Classification of Diseases for Oncology, Second Edition. Geneva: World Health Organization, 1990.
12. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13: 1087-1093.
13. Ou SH, Zell JA. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol 2009;4:1202-1211.
14. Irisa K, Masago K, Togashi Y, et al. Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptortyrosine kinase inhibitor. Med Oncol 2010. [Epub ahead of print].
15. Rivera C, Dahan M, Bernard A, et al. Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit. Eur J Cardiothorac Surg 2011;39:981-986.
16. International Agency for Research on Cancer, WHO. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer, 2004.
17. Loo PS, Thomas SC, Nicolson MC, et al. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol 2010;5:442-447.
18. Cataluna JJ, Perpina M, Greses JV, et al. Cell type accuracy of bronchial biopsy specimens in primary lung cancer. Chest 1996;109: 1199-1203. (Pubitemid 26145656)
19. Thomas JS, Lamb D, Ashcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax 1993;48:1135-1139. (Pubitemid 23336832)
20. Chuang MT, Marchevsky A, Teirstein AS, et al. Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax 1984;39:175-178. (Pubitemid 14154222)
21. Payne CR, Hadfield JW, Stovin PG, et al. Diagnostic accuracy of cytology and biopsy in primary bronchial carcinoma. J Clin Pathol 1981;34:773-778. (Pubitemid 11040320)
22. Gong Y, Sneige N, Guo M, et al. Transthoracic fine-needle aspiration vs concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective comparison of diagnostic accuracy. Am J Clin Pathol 2006;125:438-444. (Pubitemid 43327715)
23. Sackett MK, Salomao DR, Donovan JL, et al. Diagnostic concordance of histologic lung cancer type between bronchial biopsy and cytology specimens taken during the same bronchoscopic procedure. Arch Pathol Lab Med 134:1504-1512.
24. Matsuda M, Horai T, Nakamura S, et al. Bronchial brushing and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer. Thorax 1986;41:475-478. (Pubitemid 16089183)
25. Clee MD, Duguid HL, Sinclair DJ. Accuracy of morphological diagnosis of lung cancer in a department of respiratory medicine. J Clin Pathol 1982;35:414-419. (Pubitemid 12105272)
26. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184-2191. (Pubitemid 41095154)
27. Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 2009;374:1432-1440.
28. Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 2010;5:436-441.
29. Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non- small-cell lung carcinoma. J Clin Oncol 2009;27:2030-2037.
30. Sandler A, Yi J, Dahlberg S, et al. Treatment outcomes by tumor histology in Eastern Cooperative Group Study E4599 of bevacizumab with paclitaxel/carboplatin for advanced non-small cell lung cancer. J Thorac Oncol 5:1416-1423.